Association between common variation in 120 candidate genes and breast cancer risk

PLoS Genetics

Volumn 3, Issue 3, 2007, Pages 0401-0406

  Pharoah, Paul D P ^a,b   Tyrer, Jonathan ^a   Dunning, Alison M ^a   Easton, Douglas F ^b   Ponder, Bruce A J ^a   Abraham, Jean ^a   Al Zahrani, Ali ^a   Baynes, Caroline ^a   Blows, Fiona ^a   Cebrian, Arancha ^a   Conroy, Don ^a   Dew, Gary ^a   Driver, Kristy ^a   Field, Helen ^a   Gregory, Katie ^a   Harrington, Patricia ^a   Lesueur, Fabienne ^a   Luccarini, Craig ^a   Pooley, Karen ^a   Scollen, Serena ^a   Jordan, Clare ^a   Munday, Hannah ^a   Perkins, Barbara ^a   Shah, Mitul ^a   West, Judy ^a   Antoniou, Antonis ^a   Smith, Paula ^a   Thompson, Deborah ^a   Redman, Karen ^a   Luben, Robert ^a   Wareham, Nicholas ^c   Hesselson, Stephanie ^d   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC Clinical Epidemiology Unit   (United Kingdom)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CELL CYCLE REGULATION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID METABOLISM; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; TUMOR GENE;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34047201701     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0030042     Document Type: Article

References (39)

1. Collaborative group on hormonal factors in breast cancer (2001) Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358: 1389-1399.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer- analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med 343: 78-85.
3. Easton DF (1999) How many more breast cancer predisposition genes are there. Breast Cancer Res 1: 14-17.
4. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, et al. (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45: 646-655.
5. Antoniou AC, Pharoah PDP, McMullen G, Day NE, Stratton MR, et al. (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86: 76-83.
6. Risch N (2000) Searching for genetic determinants in the new millenium. Nature 405: 847-856.
7. Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2: 91-99.
8. Chakravarti A (1999) Population genetics-making sense out of sequence. Nat Genet 21: 56-60.
9. Pharoah PDP, Dunning AM, Ponder BAJ, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4: 850-860.
10. Fisher RA (1932) Statistical methods for research workers. Edinburgh: Oliver and Boyd. 307 p.
11. Wilkinson B (1951) A statistical consideration in psychological research. Psychol Bull 48: 156-158.
12. Sidak Z (1967) Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 78: 626-633.
13. Edgington ES (1972) An additive model for combining probability values from independent experiments. J Psychol 80: 351-363.
14. Simes RJ (1986) An improved Bonferroni procedure for multiple tests of significance. Biometrika 73: 751-754.
15. Hoh J, Wille A, Ott J (2001) Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 11: 2115-2119.
16. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS (2002) Truncated product method for combining P-values. Genet Epidemiol 22: 170-185.
17. Dudbridge F, Koeleman BP (2003) Rank truncated product of P-values, with application to genomewide association scans. Genet Epidemiol 25: 360-366.
18. Schaid DJ, McDonnell SK, Hebbring SJ, Cunningham JM, Thibodeau SN (2005) Nonparametric tests of association of multiple genes with human disease. Am J Hum Genet 76: 780-793.
19. Tyrer J, Pharoah PDP, Easton DF (2006) The admixture maximum likelihood test: A novel experiment-wise test of association between disease and multiple SNPs. Genet Epidemiol 30: 636-643.
20. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian SP, Reed MWR, et al. (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. E-pub 11 February 2007.
21. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P (2000) Association mapping in structured populations. Am J Hum Genet 67: 170-181.
22. Gorroochurn P, Heiman GA, Hodge SE, Greenberg DA (2006) Centralizing the non-central chi-square: A new method to correct for population stratification in genetic case-control association studies. Genet Epidemiol 30: 277-289.
23. Breast Cancer Association Consortium (2006) Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98: 1382-1396.
24. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, et al. (2004) Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96: 1866-1869.
25. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, et al. (2003) A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63: 2610-2615.
26. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
27. Devlin B, Roeder K, Bacanu SA (2001) Unbiased methods for population-based association studies. Genet Epidemiol 21: 273-284.
28. Dudbridge F (2006) A note on permutation tests in multistage association scans. Am J Hum Genet 78: 1094-1095; author reply 1096.
29. Benusiglio P, Lesueur F, Luccarini C, Conroy DM, Shah M, et al. (2005) Common polymorphisms in ERBB2 and risk of breast cancer in a white population: A case-control study. Breast Cancer Res 7: R204-R209.
30. Lesueur F, Pharoah PD, Laing S, Ahmed S, Jordan C, et al. (2005) Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Hum Mol Genet 14: 2349-2356.
31. Lesueur F, Song H, Ahmed S, Luccarini C, Jordan C, et al. (2006) Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population. Br J Cancer 94: 1921-1926.
32. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, et al. (2002) Variants in DNA double strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11: 1399-1407.
33. Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, et al. (2005) Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 1828-1831.
34. Kuschel B, Auranen A, Gregory CS, Day NE, Easton DF, et al. (2003) Common polymorphisms in CHEK2 (checkpoint kinase 2) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 12: 809-812.
35. Healey CS, Dunning AM, Dawn Teare M, Chase D, Parker L, et al. (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26: 362-364.
36. Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, et al. (2006) Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 27: 1661-1669.
37. Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, et al. (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15: 1-10.
38. Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, et al. (2006) Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer. Cancer Res 66: 1225-1233.
39. Healey CS, Dunning AM, Durocher F, Teare D, Pharoah PD, et al. (2000) Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis 21: 189-193.